SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062020
Filing Date
2023-11-09
Accepted
2023-11-09 16:06:34
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-20231109.htm   iXBRL 8-K 58418
2 EX-99.1 life-ex99_1.htm EX-99.1 197066
3 GRAPHIC img140509417_0.jpg GRAPHIC 10984
  Complete submission text file 0000950170-23-062020.txt   401548

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20231109_pre.xml EX-101.PRE 10992
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20231109.xsd EX-101.SCH 2470
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20231109_lab.xml EX-101.LAB 13360
8 EXTRACTED XBRL INSTANCE DOCUMENT life-20231109_htm.xml XML 4711
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 231392345
SIC: 2836 Biological Products, (No Diagnostic Substances)